 Krista Eschbach
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 23 | 2026 | 140 | 4.810 |
Why?
| | Status Epilepticus | 15 | 2026 | 68 | 4.110 |
Why?
| | Epilepsy | 14 | 2026 | 390 | 2.350 |
Why?
| | Epilepsies, Myoclonic | 4 | 2020 | 59 | 1.730 |
Why?
| | Seizures, Febrile | 5 | 2025 | 23 | 1.470 |
Why?
| | Anticonvulsants | 6 | 2025 | 246 | 1.050 |
Why?
| | Neuropsychological Tests | 2 | 2026 | 1134 | 0.820 |
Why?
| | Seizures | 12 | 2026 | 483 | 0.800 |
Why?
| | Gastrointestinal Diseases | 1 | 2025 | 221 | 0.770 |
Why?
| | Electroencephalography | 10 | 2026 | 561 | 0.760 |
Why?
| | Referral and Consultation | 2 | 2026 | 867 | 0.740 |
Why?
| | Developmental Disabilities | 3 | 2026 | 281 | 0.740 |
Why?
| | Neurosurgical Procedures | 4 | 2026 | 202 | 0.650 |
Why?
| | Neurology | 1 | 2021 | 116 | 0.610 |
Why?
| | Dioxolanes | 1 | 2019 | 6 | 0.590 |
Why?
| | Patient Admission | 1 | 2021 | 220 | 0.580 |
Why?
| | Nervous System Diseases | 1 | 2021 | 286 | 0.540 |
Why?
| | Brain Waves | 1 | 2018 | 45 | 0.540 |
Why?
| | Child | 31 | 2026 | 22707 | 0.530 |
Why?
| | Quality of Life | 5 | 2025 | 3204 | 0.520 |
Why?
| | Patient Safety | 1 | 2021 | 356 | 0.520 |
Why?
| | Child, Preschool | 22 | 2026 | 11853 | 0.510 |
Why?
| | Thyrotropin | 1 | 2017 | 120 | 0.510 |
Why?
| | Epileptic Syndromes | 4 | 2024 | 98 | 0.480 |
Why?
| | Caregivers | 1 | 2024 | 1073 | 0.460 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 317 | 0.440 |
Why?
| | Infant | 15 | 2026 | 10077 | 0.410 |
Why?
| | Diet, Ketogenic | 3 | 2024 | 39 | 0.400 |
Why?
| | Testosterone | 1 | 2017 | 416 | 0.390 |
Why?
| | Encephalitis | 3 | 2026 | 142 | 0.390 |
Why?
| | Adolescent | 20 | 2026 | 22529 | 0.370 |
Why?
| | Telemedicine | 1 | 2021 | 961 | 0.350 |
Why?
| | Male | 26 | 2026 | 72842 | 0.320 |
Why?
| | Female | 27 | 2026 | 78844 | 0.310 |
Why?
| | Humans | 41 | 2026 | 145474 | 0.300 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2381 | 0.280 |
Why?
| | Corpus Callosum | 2 | 2026 | 72 | 0.280 |
Why?
| | Palliative Care | 3 | 2026 | 1020 | 0.270 |
Why?
| | Cytokines | 2 | 2026 | 2067 | 0.260 |
Why?
| | Registries | 3 | 2025 | 2406 | 0.250 |
Why?
| | Young Adult | 11 | 2026 | 14218 | 0.250 |
Why?
| | Delayed Diagnosis | 1 | 2026 | 100 | 0.230 |
Why?
| | Prodromal Symptoms | 1 | 2025 | 20 | 0.220 |
Why?
| | Psychosurgery | 1 | 2023 | 9 | 0.200 |
Why?
| | Databases, Factual | 3 | 2024 | 1490 | 0.200 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 104 | 0.200 |
Why?
| | Retrospective Studies | 10 | 2025 | 17291 | 0.200 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2024 | 22 | 0.200 |
Why?
| | Middle Aged | 12 | 2026 | 36215 | 0.190 |
Why?
| | Adult | 13 | 2026 | 40777 | 0.190 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 253 | 0.190 |
Why?
| | Immunotherapy | 2 | 2025 | 666 | 0.190 |
Why?
| | Neurodevelopmental Disorders | 1 | 2026 | 227 | 0.180 |
Why?
| | Fever | 1 | 2024 | 319 | 0.180 |
Why?
| | Genetic Testing | 2 | 2022 | 480 | 0.180 |
Why?
| | Treatment Outcome | 10 | 2026 | 11772 | 0.180 |
Why?
| | Laser Therapy | 1 | 2023 | 144 | 0.170 |
Why?
| | GABA Modulators | 1 | 2021 | 11 | 0.170 |
Why?
| | Cognition Disorders | 1 | 2026 | 541 | 0.170 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2019 | 22 | 0.170 |
Why?
| | Brain Injuries | 1 | 2026 | 507 | 0.160 |
Why?
| | Interviews as Topic | 1 | 2024 | 910 | 0.160 |
Why?
| | Deep Brain Stimulation | 1 | 2024 | 219 | 0.160 |
Why?
| | Cerebral Palsy | 1 | 2022 | 137 | 0.150 |
Why?
| | Spasms, Infantile | 1 | 2021 | 138 | 0.150 |
Why?
| | Cohort Studies | 5 | 2026 | 6013 | 0.150 |
Why?
| | Cross-Sectional Studies | 5 | 2026 | 5904 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2026 | 735 | 0.140 |
Why?
| | Drug Approval | 1 | 2019 | 93 | 0.140 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2018 | 19 | 0.140 |
Why?
| | Communication | 1 | 2024 | 975 | 0.130 |
Why?
| | Pediatrics | 1 | 2026 | 1121 | 0.130 |
Why?
| | Body Height | 1 | 2017 | 202 | 0.120 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5423 | 0.120 |
Why?
| | Neurofilament Proteins | 2 | 2026 | 79 | 0.110 |
Why?
| | Surveys and Questionnaires | 2 | 2026 | 6066 | 0.110 |
Why?
| | Inflammation | 1 | 2025 | 2878 | 0.100 |
Why?
| | Body Weight | 1 | 2017 | 971 | 0.100 |
Why?
| | Mutation | 3 | 2021 | 4075 | 0.100 |
Why?
| | Aged | 7 | 2026 | 26153 | 0.090 |
Why?
| | Quality Improvement | 1 | 2021 | 1295 | 0.090 |
Why?
| | Prospective Studies | 4 | 2026 | 8057 | 0.090 |
Why?
| | United States | 2 | 2026 | 16098 | 0.080 |
Why?
| | Infant, Newborn | 3 | 2024 | 6447 | 0.060 |
Why?
| | Risk Factors | 1 | 2021 | 10885 | 0.060 |
Why?
| | S100 Calcium Binding Protein beta Subunit | 1 | 2026 | 9 | 0.060 |
Why?
| | Blood Cell Count | 1 | 2025 | 55 | 0.060 |
Why?
| | Atrophy | 1 | 2025 | 199 | 0.050 |
Why?
| | Biomarkers | 2 | 2026 | 4295 | 0.050 |
Why?
| | Florida | 1 | 2024 | 117 | 0.050 |
Why?
| | Rituximab | 1 | 2024 | 210 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 217 | 0.050 |
Why?
| | Probability | 1 | 2023 | 307 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3904 | 0.040 |
Why?
| | Subdural Space | 1 | 2021 | 7 | 0.040 |
Why?
| | Stereotaxic Techniques | 1 | 2021 | 42 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2026 | 308 | 0.040 |
Why?
| | Preoperative Care | 1 | 2024 | 380 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 147 | 0.040 |
Why?
| | Infectious Encephalitis | 1 | 2020 | 2 | 0.040 |
Why?
| | Neuroimaging | 1 | 2023 | 297 | 0.040 |
Why?
| | Electrodes, Implanted | 1 | 2021 | 114 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2021 | 37 | 0.040 |
Why?
| | Valproic Acid | 1 | 2020 | 49 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 147 | 0.040 |
Why?
| | Animals | 2 | 2021 | 38030 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 653 | 0.040 |
Why?
| | Internet | 1 | 2025 | 689 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2025 | 2121 | 0.040 |
Why?
| | Family | 1 | 2024 | 682 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 588 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 251 | 0.040 |
Why?
| | DNA Polymerase gamma | 1 | 2019 | 8 | 0.040 |
Why?
| | Cannabinoids | 1 | 2021 | 184 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2019 | 38 | 0.040 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 48 | 0.040 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 42 | 0.040 |
Why?
| | Cannabidiol | 1 | 2021 | 142 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 992 | 0.030 |
Why?
| | Family Health | 1 | 2019 | 191 | 0.030 |
Why?
| | Activities of Daily Living | 1 | 2021 | 444 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2019 | 137 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 221 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3342 | 0.030 |
Why?
| | Anxiety | 1 | 2025 | 1118 | 0.030 |
Why?
| | Prognosis | 1 | 2025 | 4316 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1061 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 591 | 0.030 |
Why?
| | Time Factors | 1 | 2025 | 7123 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3155 | 0.020 |
Why?
| | Brain | 1 | 2025 | 2947 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1480 | 0.020 |
Why?
|
|
Eschbach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|